Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Pliant Therapeutics, Inc.

Clinical trials sponsored by Pliant Therapeutics, Inc., explained in plain language.

Pliant Therapeutics, Inc. PLRX NASDAQ

A clinical-stage biopharmaceutical company developing treatments for fibrosis.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Completed 2 Terminated 1

New hope for tumors that beat immunotherapy? early trial launches

Disease control Recruiting now

This early-phase study tests a new drug (PLN-101095) alone or with pembrolizumab in adults whose advanced solid tumors have stopped responding to standard immunotherapy. About 124 participants will receive the treatment to check safety and early signs of tumor shrinkage. The goal…

Phase: PHASE1 • Sponsor: Pliant Therapeutics, Inc. • Aim: Disease control

Last updated Aug 05, 2026 00:00 UTC